286 related articles for article (PubMed ID: 30039416)
1. The Use of Dynamic Pharmacophore in Computer-Aided Hit Discovery: A Case Study.
Perricone U; Wieder M; Seidel T; Langer T; Padova A
Methods Mol Biol; 2018; 1824():317-333. PubMed ID: 30039416
[TBL] [Abstract][Full Text] [Related]
2. A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α.
Perricone U; Wieder M; Seidel T; Langer T; Padova A; Almerico AM; Tutone M
ChemMedChem; 2017 Aug; 12(16):1399-1407. PubMed ID: 28135036
[TBL] [Abstract][Full Text] [Related]
3. Exploiting Water Dynamics for Pharmacophore Screening.
Schaller D; Pach S; Bermudez M; Wolber G
Methods Mol Biol; 2021; 2266():227-238. PubMed ID: 33759130
[TBL] [Abstract][Full Text] [Related]
4. Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles.
Lans I; Palacio-Rodríguez K; Cavasotto CN; Cossio P
J Comput Aided Mol Des; 2020 Oct; 34(10):1063-1077. PubMed ID: 32656619
[TBL] [Abstract][Full Text] [Related]
5. Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations.
Polishchuk P; Kutlushina A; Bashirova D; Mokshyna O; Madzhidov T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757043
[TBL] [Abstract][Full Text] [Related]
6. Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations.
Wieder M; Garon A; Perricone U; Boresch S; Seidel T; Almerico AM; Langer T
J Chem Inf Model; 2017 Feb; 57(2):365-385. PubMed ID: 28072524
[TBL] [Abstract][Full Text] [Related]
7. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
8. AutoPH4: An Automated Method for Generating Pharmacophore Models from Protein Binding Pockets.
Jiang S; Feher M; Williams C; Cole B; Shaw DE
J Chem Inf Model; 2020 Sep; 60(9):4326-4338. PubMed ID: 32639159
[TBL] [Abstract][Full Text] [Related]
9. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
10. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
[TBL] [Abstract][Full Text] [Related]
11. Multi-conformation dynamic pharmacophore modeling of the peroxisome proliferator-activated receptor γ for the discovery of novel agonists.
Sohn YS; Park C; Lee Y; Kim S; Thangapandian S; Kim Y; Kim HH; Suh JK; Lee KW
J Mol Graph Model; 2013 Nov; 46():1-9. PubMed ID: 24104184
[TBL] [Abstract][Full Text] [Related]
12. Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships.
Naqvi AAT; Mohammad T; Hasan GM; Hassan MI
Curr Top Med Chem; 2018; 18(20):1755-1768. PubMed ID: 30360721
[TBL] [Abstract][Full Text] [Related]
13. Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies.
Lone MY; Manhas A; Athar M; Jha PC
J Biomol Struct Dyn; 2018 Aug; 36(11):2951-2965. PubMed ID: 28849732
[TBL] [Abstract][Full Text] [Related]
14. An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge.
Perricone U; Gulotta MR; Lombino J; Parrino B; Cascioferro S; Diana P; Cirrincione G; Padova A
Medchemcomm; 2018 Jun; 9(6):920-936. PubMed ID: 30108981
[TBL] [Abstract][Full Text] [Related]
15. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents.
Cele FN; Ramesh M; Soliman ME
Drug Des Devel Ther; 2016; 10():1365-77. PubMed ID: 27114700
[TBL] [Abstract][Full Text] [Related]
16. Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations.
Lee JY; Krieger JM; Li H; Bahar I
Protein Sci; 2020 Jan; 29(1):76-86. PubMed ID: 31576621
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
[TBL] [Abstract][Full Text] [Related]
18. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
Singh K; Bhushan B; Singh B
Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors.
Samanta PN; Kar S; Leszczynski J
Curr Pharm Des; 2019; 25(7):750-773. PubMed ID: 30836910
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors.
Hoi PM; Li S; Vong CT; Tseng HH; Kwan YW; Lee SM
Methods; 2015 Jan; 71():85-91. PubMed ID: 25239735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
